1. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System 
M.E.A. de Kraker, V. Jarlier, J.C.M. Monen, O.E. Heuer, N. van de Sande, H. Grundmann 
Clinical Microbiology and Infection 
Volume 19, Issue 9, Pages (September 2013)
DOI: /
Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

2. Fig. 1
Trends in the total number of Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Enterococcus faecium and Enterococcus faecalis bacteraemia isolates reported to the European Antimicrobial Resistance Surveillance System between 2002 and Only laboratories that consistently reported for all years were included.
Clinical Microbiology and Infection  , DOI: ( / )
Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

3. Fig. 2
Total number of Escherichia coli bacteraemia isolates with different resistance phenotypes reported to the European Antimicrobial Resistance Surveillance System between 2002 and Only laboratories that consistently reported for all years were included. R = resistance; G3C = third-generation cephalosporins; FQ = fluoroquinolones; amipn = aminopenicillins. For reasons of clarity, combined resistance proportions for aminoglycosides are exclusively displayed in a Table.
Clinical Microbiology and Infection  , DOI: ( / )
Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

4. Fig. 3
Relative increase in the number of Escherichia coli bacteraemia isolates with different resistance phenotypes (index year = 2002) reported to the European Antimicrobial Resistance Surveillance System between 2002 and Only laboratories that consistently reported for all years were included. Symbols indicate ascertained values and lines are based on generalized linear models with Poisson distribution. Numbers and the average annual increase per phenotype are displayed in the table. R = resistance; G3C = third-generation cephalosporins; FQ = fluoroquinolones; amino = aminoglycosides; amipn = aminopenicillins.
Clinical Microbiology and Infection  , DOI: ( / )
Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions